Technology Review - Published By MIT
Advertisement
TR35

2005 Young Innovator

Kevin Eggan, 31

Harvard University

Using cloning to study degenerative diseases

While earning his PhD, Kevin Eggan helped make Rudolf Jaenischs lab at the Whitehead Institute for Biomedical Research a preeminent cloning lab. Eggan became "arguably the most skillful mouse cloner in this country," says Jaenisch. Eggan used those skills to clone mice from neurons, proving that animals could be cloned from even the most specialized cells in the body -- a feat that many scientists considered impossible. Eggan also helped explain how cloning "reprograms" the genetic material from an adult mouse cell, identifying the changes that take place to reset the nucleus to the beginning of development.

Eggan, now an assistant professor of molecular and cellular biology, plans to create human stem cell lines from patients with neurodegenerative disorders such as Parkinsons and Lou Gehrigs diseases, in order to study disease development and search for new drugs. He has also begun studying nuclear reprogramming in human cells in the hope of finding a way to create patient-specific embryonic stem cells without using human eggs.

 
 
TR35 Back to all TR35 2005 Winners   TR35 2005 Biotech Winners     
Thijn Brummelkamp
Silencing the genes that cause cancer
Martha Bulyk
Discovering how genes are regulated
Matthew DeLisa
Delivering more medicine from microbes
Kevin Eggan
Using cloning to study degenerative diseases
Paul Hergenrother
Discovering drugs that defy convention
Trey Ideker
Defining and advancing systems biology
Hang Lu
Designing microfluidic chips to study cells
Melissa Mahoney
Making materials to treat brain damage
Daniel Riskin
Developing devices for wound closure and early heart-attack intervention.
Shiladitya Sengupta
Delivering drugs to cancer cells

Comments

Advertisement
MIT Massachusetts Institute of Technology © 2010 Technology Review. All Rights Reserved.